QIAGEN Reports First Quarter 2014 Results and Authorizes New $100 Million Share Repurchase Program
[PR Newswire] – Achieved targets: Adjusted net sales of $317.4 million (+5% CER) on growth in all regions and customer classes; Adjusted net sales rise approximately 9% CER excluding U.S. HPV test products more
View todays social media effects on QGEN
View the latest stocks trending across Twitter. Click to view dashboard